
Czech Republic - Hormones, Prostaglandins, Thromboxanes and Leukotrienes - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingCzech Republic: Market for Hormones, Prostaglandins, Thromboxanes And Leukotrienes 2025
Market Size for Hormones, Prostaglandins, Thromboxanes And Leukotrienes in the Czech Republic
In 2021, the Czech market for hormones, prostaglandins, thromboxanes and leukotrienes decreased by -5.9% to $X for the first time since 2016, thus ending a four-year rising trend. Overall, consumption, however, recorded buoyant growth. As a result, consumption attained the peak level of $X, and then declined in the following year.
Production of Hormones, Prostaglandins, Thromboxanes And Leukotrienes in the Czech Republic
In value terms, hormones, prostaglandins, thromboxanes and leukotrienes production dropped to $X in 2021 estimated in export price. Over the period under review, the total production indicated a resilient expansion from 2012 to 2021: its value increased at an average annual rate of +7.4% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, production increased by +90.3% against 2012 indices. The pace of growth appeared the most rapid in 2020 with an increase of 34% against the previous year. As a result, production reached the peak level of $X, and then declined in the following year.
Exports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes
Exports from the Czech Republic
In 2021, the amount of hormones, prostaglandins, thromboxanes and leukotrienes exported from the Czech Republic surged to X tons, increasing by 135% on the previous year. In general, exports continue to indicate a strong increase. As a result, the exports attained the peak and are likely to continue growth in the immediate term.
In value terms, hormones, prostaglandins, thromboxanes and leukotrienes exports soared to $X in 2021. Overall, exports posted significant growth. The most prominent rate of growth was recorded in 2020 with an increase of 176% against the previous year. The exports peaked in 2021 and are likely to continue growth in the immediate term.
Exports by Country
Germany (X tons) was the main destination for hormones, prostaglandins, thromboxanes and leukotrienes exports from the Czech Republic, with a 66% share of total exports. Moreover, hormones, prostaglandins, thromboxanes and leukotrienes exports to Germany exceeded the volume sent to the second major destination, Italy (X kg), fivefold. The third position in this ranking was taken by Poland (X kg), with a 12% share.
From 2012 to 2021, the average annual growth rate of volume to Germany totaled +35.3%. Exports to the other major destinations recorded the following average annual rates of exports growth: Italy (+47.8% per year) and Poland (+15.3% per year).
In value terms, the largest markets for hormones, prostaglandins, thromboxanes and leukotrienes exported from the Czech Republic were Italy ($X), Germany ($X) and Spain ($X), with a combined 94% share of total exports. These countries were followed by France, Poland and Slovakia, which together accounted for a further 1.4%.
In terms of the main countries of destination, France, with a CAGR of +78.3%, recorded the highest rates of growth with regard to the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.
Export Prices by Country
The average export price for hormones, prostaglandins, thromboxanes and leukotrienes stood at $X per kg in 2021, which is down by -16.2% against the previous year. Over the period under review, the export price, however, enjoyed a buoyant increase. The growth pace was the most rapid in 2020 an increase of 67%. As a result, the export price reached the peak level of $X per kg, and then declined remarkably in the following year.
There were significant differences in the average prices for the major export markets. In 2021, the country with the highest price was Italy ($X per kg), while the average price for exports to Poland ($X per kg) was amongst the lowest.
From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to Italy (+13.6%), while the prices for the other major destinations experienced more modest paces of growth.
Imports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes
Imports into the Czech Republic
In 2021, the amount of hormones, prostaglandins, thromboxanes and leukotrienes imported into the Czech Republic skyrocketed to X tons, with an increase of 34% compared with 2020. Overall, imports saw a strong increase. The pace of growth appeared the most rapid in 2019 when imports increased by 266% against the previous year. Imports peaked in 2021 and are likely to continue growth in years to come.
In value terms, hormones, prostaglandins, thromboxanes and leukotrienes imports rose notably to $X in 2021. In general, total imports indicated resilient growth from 2012 to 2021: its value increased at an average annual rate of +8.0% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, imports decreased by -1.1% against 2019 indices. The growth pace was the most rapid in 2013 with an increase of 46%. Over the period under review, imports hit record highs at $X in 2019; however, from 2020 to 2021, imports failed to regain momentum.
Imports by Country
In 2021, Ireland (X tons) constituted the largest supplier of hormones, prostaglandins, thromboxanes and leukotrienes to the Czech Republic, with a 73% share of total imports. Moreover, hormones, prostaglandins, thromboxanes and leukotrienes imports from Ireland exceeded the figures recorded by the second-largest supplier, China (X tons), fivefold. The third position in this ranking was held by Mexico (X kg), with a 2.9% share.
From 2012 to 2021, the average annual growth rate of volume from Ireland amounted to +24.3%. The remaining supplying countries recorded the following average annual rates of imports growth: China (+22.7% per year) and Mexico (+9.5% per year).
In value terms, the largest hormones, prostaglandins, thromboxanes and leukotrienes suppliers to the Czech Republic were Ireland ($X), Mexico ($X) and China ($X), together comprising 57% of total imports.
Among the main suppliers, Ireland, with a CAGR of +36.7%, recorded the highest rates of growth with regard to the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.
Import Prices by Country
In 2021, the average import price for hormones, prostaglandins, thromboxanes and leukotrienes amounted to $X per kg, falling by -15.8% against the previous year. In general, the import price recorded a noticeable shrinkage. The most prominent rate of growth was recorded in 2014 an increase of 91% against the previous year. Over the period under review, average import prices hit record highs at $X per kg in 2018; however, from 2019 to 2021, import prices failed to regain momentum.
There were significant differences in the average prices amongst the major supplying countries. In 2021, the country with the highest price was Mexico ($X per kg), while the price for Ireland ($X per kg) was amongst the lowest.
From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Sweden (+14.0%), while the prices for the other major suppliers experienced more modest paces of growth.
Source: IndexBox Platform
Frequently Asked Questions (FAQ) :
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in the Czech Republic. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21105200 - Hormones, prostaglandins, thromboxanes and leukotrienes, n atural or reproduced by synthesis, derivatives and structural analogues thereof, including chain modified polypeptides, u sed primarily as hormones
Country coverage:
- Czech Republic
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in the Czech Republic
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND THE AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDSThis Chapter is Available Only for the Professional EditionPRO
3. MARKET OVERVIEW
Understanding the Current State of The Market and its Prospects
- MARKET SIZE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- MARKET STRUCTURE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- TRADE BALANCE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- PER CAPITA CONSUMPTION: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- MARKET FORECAST TO 2035
4. MOST PROMISING PRODUCTS FOR DIVERSIFICATION
Finding New Products to Diversify Your Business
- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCTS
- MOST TRADED PRODUCTS
- MOST PROFITABLE PRODUCTS FOR EXPORTS
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Export
- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- IMPORTS BY COUNTRY: HISTORICAL DATA (2012–2024)
- IMPORT PRICES BY COUNTRY: HISTORICAL DATA (2012–2024)
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- EXPORTS BY COUNTRY: HISTORICAL DATA (2012–2024)
- EXPORT PRICES BY COUNTRY: HISTORICAL DATA (2012–2024)
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
LIST OF TABLES
- Key Findings In 2024
- Market Volume, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Value: Historical Data (2012–2024) and Forecast (2025–2035)
- Per Capita Consumption: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Physical Terms, By Country, 2012–2024
- Imports, In Value Terms, By Country, 2012–2024
- Import Prices, By Country, 2012–2024
- Exports, In Physical Terms, By Country, 2012–2024
- Exports, In Value Terms, By Country, 2012–2024
- Export Prices, By Country, 2012–2024
LIST OF FIGURES
- Market Volume, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Value: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Structure – Domestic Supply vs. Imports, in Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Structure – Domestic Supply vs. Imports, in Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Trade Balance, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Trade Balance, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Per Capita Consumption: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Volume Forecast to 2035
- Market Value Forecast to 2035
- Market Size and Growth, By Product
- Average Per Capita Consumption, By Product
- Exports and Growth, By Product
- Export Prices and Growth, By Product
- Production Volume and Growth
- Exports and Growth
- Export Prices and Growth
- Market Size and Growth
- Per Capita Consumption
- Imports and Growth
- Import Prices
- Production, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Production, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Physical Terms, By Country, 2024
- Imports, In Physical Terms, By Country, 2012–2024
- Imports, In Value Terms, By Country, 2012–2024
- Import Prices, By Country, 2012–2024
- Exports, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Exports, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Exports, In Physical Terms, By Country, 2024
- Exports, In Physical Terms, By Country, 2012–2024
- Exports, In Value Terms, By Country, 2012–2024
- Export Prices, By Country, 2012–2024
Recommended reports
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in Asia.
This report provides an in-depth analysis of the global market for hormones, prostaglandins, thromboxanes and leukotrienes.
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in the EU.
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in the U.S..
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in China.